Tirzepatide is a new class of medication that has shown tremendous promise in the treatment of type 2 diabetes and, more recently, in weight management. Tirzepatide works by mimicking two natural hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which play critical roles in regulating blood sugar and appetite. By activating these hormone receptors, Tirzepatide help to control blood sugar levels, reduce hunger, and promote a feeling of fullness, making it easier for individuals to lose weight and maintain a healthier lifestyle.
Tirzepatide was originally developed to treat type 2 diabetes, with the goal of improving glycemic control. Early clinical trials demonstrated that Tirzepatide not only effectively managed blood sugar but also led to significant weight loss in patients. These promising results sparked further research into their potential as a weight loss treatment. In 2022, Tirzepatide were recognized for their dual action on GLP-1 and GIP receptors, offering a unique and highly effective approach to weight management. As a result, Tirzepatide have quickly become one of the most exciting developments in the field of metabolic health and weight loss.
The most well-known brand of Tirzepatide currently available is Mounjaro, which has been approved by the FDA for the treatment of type 2 diabetes and is widely prescribed for weight loss as well. Mounjaro has gained attention for its remarkable effectiveness in helping patients achieve significant and sustained weight loss, even among those who have struggled with other weight loss methods. As research continues, it’s likely that more brands and formulations of Tirzepatide will become available, further expanding its use in medical weight management.
Tirzepatide offer a range of benefits that make them a powerful tool in the fight against obesity and related health issues:
Among patients without diabetes, administering tirzepatide 5 to 15 mg once weekly for managing obesity led to remarkable reductions in body weight, ranging from 16.5% to 22.4% over 72 weeks” (Ref. Study)
Tirzepatide works by mimicking the effects of two hormones and binding to both GLP-1 and GIP receptors, making it a dual-action agonist. When bound to these receptors, the pancreas is signaled to produce insulin which regulates blood sugar. Additionally, gastric emptying is slowed down causing you to feel full for longer and reduce cravings. This combination of glycemic control, and feelings of satiety are the hallmarks of this novel medication.
Tirzepatide is typically recommended for individuals with a BMI of 30 or higher, or for those with a BMI of 27 or higher who have obesity-related health conditions. A consultation at Figura Medspa will help determine if Tirzepatide is right for you.
Tirzepatide is administered as a once-weekly injection. Our team will provide you with detailed instructions on how to self-administer the injection, or you can choose to have it administered at our medspa.
Common side effects of Tirzepatide include nausea, vomiting, diarrhea, and mild digestive discomfort, which typically decrease over time as your body adjusts to the medication. Our team will monitor your progress and adjust your treatment as needed to minimize side effects.
Many patients begin to see weight loss within the first few weeks of treatment, with more significant results becoming evident over several months. Consistency with the medication and lifestyle changes is key to achieving optimal results.
Tirzepatide and Semaglutide are both in the class of drugs known as incretin mimetics but there are some differences between the two. While semaglutide acts only on GLP-1 receptors, tirzepatide acts on both GLP-1 and GIP receptors. Both are effective treatments for weight loss, however responses to these medications may vary depending on the individual, as with any other medication. Our licensed medical team will work with you to find the option that is safest and most effective in achieving your weight-loss goals.
Some studies have shown greater weight-loss in participants using tirzepatide vs. semaglutide. However, there are limitations to these studies due to variables like diet, exercise, and diversity of participants. As with all medications, individuals may respond differently so it is important to have options. Our licensed medical professionals are here to tailor your treatment to your needs, achieving the safest and optimal outcome.
Wheather you’re looking for a younger youthful look or a slimmer body, Figura has you covered.